Quantcast

Latest Management of cancer Stories

2014-09-09 08:31:36

Additional Data Acceptances Include Multiple Oncotype DX® Studies in Breast and Renal Cancers REDWOOD CITY, Calif., Sept. 9, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX(®) in prostate, breast and renal cancers will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, September 26 - 30. Included in the program is the first presentation of strongly positive results from an...

2014-09-05 20:21:03

Horses with melanoma are the subject of this major clinical study TAMPA, Fla., Sept. 5, 2014 /PRNewswire/ -- Morphogenesis Inc., the biotechnology firm developing ImmuneFx(TM), a cancer vaccine that has improved the longevity and quality of life for dogs, cats and horses, announces that a formal equine clinical trial for the direct injection form of the vaccine will begin later this month at a large equine facility in Missouri. Pat Lawman, PhD., co-founder and CEO of Morphogenesis...

2014-08-29 16:23:39

DUBLIN, Aug. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The conventional methods developed to prevent and eradicate the prevalence of cancer have achieved limited success in cancer treatment. These methods are confined to low specificity, safety and large number of side effects, which prompted the...

2014-08-27 23:08:41

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC) for prostate cancer therapy. Under the agreement, Catalent will initially produce the antibody for a clinical study with a view to larger scale production subject...

botox for gastric cancer
2014-08-23 05:56:29

Eric Hopton for redOrbit.com - Your Universe Online Botox is in the news again, and this time it looks like potentially good news for some cancer treatments. Although it still receives mixed reviews as a result of its association with cosmetic procedures and some high-profile failures, the medical world is discovering new ways in which Botox can help treat a wide range of conditions. In a new process which has been described as “cheap, safe and efficient,” researchers have found...

2014-08-15 23:06:41

AccuBoost Announces First Breast Cancer Patient Treatments at the Midwestern Regional Medical Center in Zion, IL Tyngsboro, MA (PRWEB) August 15, 2014 Advanced Radiation Therapy, creators of the AccuBoost Breast Brachytherapy technology, is pleased to announce that it has entered into an agreement with the Midwestern Regional Medical Center of Zion, IL to offer the AccuBoost treatment option to their patients undergoing breast conservation therapy (BCT). Treatments utilizing the AccuBoost...

venom fights cancer
2014-08-13 05:35:26

redOrbit Staff & Wire Reports - Your Universe Online Bee stings and snake bites are not typically viewed as things that are beneficial to a person’s health, but new research out of the University of Illinois suggests that they could be powerful tools in the treatment of cancer. [ Watch: Treating Cancer With Venom ] In research presented at the 248th National Meeting of the American Chemical Society (ACS) in San Francisco, California on Monday, Dr. Dipanjan Pan described how...

2014-08-11 08:29:09

Patented Technology Enables Accurate Delivery of a Chemotherapeutic Drug to Targeted Tumor Cells, Reducing Drug-related Toxicity without Sacrificing Therapeutic Impact SYDNEY, Aug. 11, 2014 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No....

2014-08-05 08:33:13

Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug. 5, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today publication of a case study in which the company's comprehensive tumor profiling service, Caris Molecular Intelligence(TM), helped guide successful...

2014-07-30 08:31:59

SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as chairman of Epic's board of directors. Mr. Lucier was previously chairman and CEO of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic's board of directors to provide expertise as Epic commercializes its circulating...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.